Viewing StudyNCT00403767

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-05 @ 5:11 PM
Last Modification Date: 2024-10-26 @ 9:29 AM
Study NCT ID: NCT00403767
Status: COMPLETED
Last Update Posted: 2014-04-29
First Post: 2006-11-23
Brief Title: An Efficacy and Safety Study of Rivaroxaban With Warfarin for the Prevention of Stroke and Non-Central Nervous System Systemic Embolism in Patients With Non-Valvular Atrial Fibrillation
Sponsor: Johnson Johnson Pharmaceutical Research Development LLC
Organization: Johnson Johnson Pharmaceutical Research Development LLC
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Embolism
Atrial Fibrillation
Stroke
Keywords:
Name View
Arrhythmias Cardiac View
Atrial Fibrillation View
Stroke View
Embolism View
Non-central nervous system systemic embolism View
Non-valvular atrial fibrillation View
Blood Clot View
Rivaroxaban View
Warfarin View
Anticoagulants View